<p>Active components such as tea polyphenols and theanine in black tea, as well as walnut peptides, all exhibit immunomodulatory effects. This study evaluated the immunomodulatory effects of combined intervention with black tea aqueous extract and walnut peptides (FT-WP) in a cyclophosphamide (Cy)-induced immunosuppressed mouse model. Compared with the model group, FT-WP treatment significantly increased body weight, spleen and thymus indices, and alleviated spleen atrophy (<i>P</i> &lt; 0.05). It also elevated serum levels of immunoglobulins (IgG, IgM) and cytokines (IFN-γ), and improved the CD4 + T-cell balance in the jejunum. Non-targeted metabolomics revealed that FT-WP ameliorated Cy-induced metabolic disorders by regulating key metabolites—such as choline, trimethylamine-N-oxide, and prostaglandin F2β—primarily through the glycine/serine/threonine metabolic pathway. In conclusion, the FT-WP combination effectively alleviates immunosuppression by synergistically regulating immune organ function, intestinal immunity, and metabolic networks, providing a scientific basis for the development of novel functional immunomodulatory products.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Effect and mechanism of combined intervention of black tea aqueous extract and walnut peptide on immune-metabolic homeostasis of cyclophosphamide-induced immunosuppressive mice

  • Wei Liu,
  • Xi Chu,
  • Difei Yang,
  • Yufei Zhou,
  • Zhonghua Liu,
  • Sheng Zhang,
  • Ailing Liu

摘要

Active components such as tea polyphenols and theanine in black tea, as well as walnut peptides, all exhibit immunomodulatory effects. This study evaluated the immunomodulatory effects of combined intervention with black tea aqueous extract and walnut peptides (FT-WP) in a cyclophosphamide (Cy)-induced immunosuppressed mouse model. Compared with the model group, FT-WP treatment significantly increased body weight, spleen and thymus indices, and alleviated spleen atrophy (P < 0.05). It also elevated serum levels of immunoglobulins (IgG, IgM) and cytokines (IFN-γ), and improved the CD4 + T-cell balance in the jejunum. Non-targeted metabolomics revealed that FT-WP ameliorated Cy-induced metabolic disorders by regulating key metabolites—such as choline, trimethylamine-N-oxide, and prostaglandin F2β—primarily through the glycine/serine/threonine metabolic pathway. In conclusion, the FT-WP combination effectively alleviates immunosuppression by synergistically regulating immune organ function, intestinal immunity, and metabolic networks, providing a scientific basis for the development of novel functional immunomodulatory products.